Literature DB >> 1368020

Ribozymes.

J J Rossi1.   

Abstract

RNA enzymes or ribozymes are receiving considerable attention for their potential use as highly specific inhibitors of gene expression. From the basic science perspective, the mechanisms by which ribozymes catalyze site-specific cleavage (and in some cases ligation) reactions provide exciting and active areas of scientific investigation. The most recent developments in our understanding of the molecular mechanisms of catalysis, as well as in vivo applications of ribozymes, are highlighted.

Mesh:

Substances:

Year:  1992        PMID: 1368020     DOI: 10.1016/0958-1669(92)90117-2

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  10 in total

Review 1.  Gene therapy for carcinoma of the breast.

Authors:  M A Stoff-Khalili; P Dall; D T Curiel
Journal:  Cancer Gene Ther       Date:  2006-01-06       Impact factor: 5.987

2.  The efficiency of a cis-cleaving ribozyme in an mRNA coding region is influenced by the translating ribosome in vivo.

Authors:  S Zhang; M Stancek; L A Isaksson
Journal:  Nucleic Acids Res       Date:  1997-11-01       Impact factor: 16.971

3.  Rescue of abasic hammerhead ribozymes by exogenous addition of specific bases.

Authors:  A Peracchi; L Beigelman; N Usman; D Herschlag
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

4.  Discrimination of a single base change in a ribozyme using the gene for dihydrofolate reductase as a selective marker in Escherichia coli.

Authors:  S Fujita; T Koguma; J Ohkawa; K Mori; T Kohda; H Kise; S Nishikawa; M Iwakura; K Taira
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

Review 5.  Inhibition of gene expression with ribozymes.

Authors:  P Marschall; J B Thomson; F Eckstein
Journal:  Cell Mol Neurobiol       Date:  1994-10       Impact factor: 5.046

Review 6.  Colocalizing ribozymes with substrate RNAs to increase their efficacy as gene inhibitors.

Authors:  B A Sullenger
Journal:  Appl Biochem Biotechnol       Date:  1995 Jul-Sep       Impact factor: 2.926

7.  Evaluating group I intron catalytic efficiency in mammalian cells.

Authors:  M B Long; B A Sullenger
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

Review 8.  Anti-HIV ribozymes.

Authors:  L Q Sun; J A Ely; W Gerlach; G Symonds
Journal:  Mol Biotechnol       Date:  1997-06       Impact factor: 2.860

9.  Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.

Authors:  L Q Sun; L Wang; W L Gerlach; G Symonds
Journal:  Nucleic Acids Res       Date:  1995-08-11       Impact factor: 16.971

Review 10.  The application of ribozymes and DNAzymes in muscle and brain.

Authors:  Nikolaos P Mastroyiannopoulos; James B Uney; Leonidas A Phylactou
Journal:  Molecules       Date:  2010-08-09       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.